AN ACT TO AMEND THE SOUTH CAROLINA CODE OF LAWS BY AMENDING SECTION 44-53-398, RELATING TO THE SALE OF PROD...
This bill amends regulations on the sale of products containing ephedrine, pseudoephedrine, or phenylpropanolamine. It mandates that manufacturers pay monthly fees related to data collection and establishes penalties for non-compliance.
Do you support it?
Want to know if it passes?
We'll email you when H 4382 moves — a committee vote, a floor vote, or a signature. Nothing else.
Free forever · unsubscribe in one click.
Your answer was recorded either way.
Which district are you in?
Your ZIP is all we need to match you to your own representatives — so we can tell you how they voted on H 4382.
You're tracking H 4382
We'll email you the moment it moves.
H 4382 — AN ACT TO AMEND THE SOUTH CAROLINA CODE OF LAWS BY AMENDING SECTION 44-53-398, RELATING TO THE SALE OF PRODUCTS CONTAINING EPHEDRINE, PSEUDOEPHEDRINE, OR PHENYLPROPANOLAMINE, SO AS TO REQUIRE THAT MANUFACTURERS OF THESE PRODUCTS PAY MONTHLY FEES ASSOCIATED WITH DATA COLLECTION, TO ESTABLISH A PENALTY FOR MANUFACTURERS THAT FAIL TO COMPLY, AND FOR OTHER PURPOSES. - RATIFIED TITLE
Last action — Act No. 235
No card. One bill, free forever — alerts when it moves.
-
✓Introduced
-
✓In Committee
-
✓Passed House
-
✓Passed Senate
-
✓To Executive
-
6Enacted
This bill has been enacted into law. Introduced April 23, 2025. Enacted.
Signed by Governor Henry McMaster (Republican) on May 19, 2026.
Prognosis
Where this bill stands today.
Odds of enactment
HighHow often bills like it became law.
-
Enacted
Current position in the legislative process.
-
1 sponsor
1 primary, 0 co-sponsors signed on.
Prognosis reads this bill's own signals — stage, sponsorship breadth, committee status, recorded votes and cross-state momentum. Odds come from a model trained on which bills have become law.
In plain language
The bill requires manufacturers of certain products to pay monthly fees for data collection.
This bill amends regulations on the sale of products containing ephedrine, pseudoephedrine, or phenylpropanolamine. It mandates that manufacturers pay monthly fees related to data collection and establishes penalties for non-compliance.
What this means for you
- Small Business: Manufacturers of these products will need to manage new monthly fees and potential penalties.
Summary
Nonprescription Ephedrine Products
Bill Text
- Full text View text Current html
Action History
-
Effective date 05/19/26
-
Act No. 235
-
Signed By Governor
-
Ratified R 248
-
Roll call Yeas-111 Nays-0 (House Journal-page 37)
-
Concurred in Senate amendment and enrolled (House Journal-page 36)
-
Scrivener's error corrected
-
Read third time and returned to House with amendments (Senate Journal-page 60)
-
Scrivener's error corrected
-
Roll call Ayes-46 Nays-0 (Senate Journal-page 54)
-
Read second time (Senate Journal-page 54)
-
Amended (Senate Journal-page 54)
-
Committee report: Favorable Medical Affairs (Senate Journal-page 6)
-
Referred to Committee on Medical Affairs (Senate Journal-page 7)
-
Introduced and read first time (Senate Journal-page 7)
-
Read third time and sent to Senate (House Journal-page 125)
-
Roll call Yeas-112 Nays-0 (House Journal-page 152)
-
Read second time (House Journal-page 148)
-
Amended (House Journal-page 148)
-
Debate adjourned (House Journal-page 170)
-
Requests for debate-Rep(s). Frank, Edgerton, Pace, Beach, Harris, Gilreath, Cromer, Terribile (House Journal-page 34)
-
Committee report: Favorable with amendment Labor, Commerce and Industry (House Journal-page 17)
-
Referred to Committee on Labor, Commerce and Industry (House Journal-page 49)
-
Introduced and read first time (House Journal-page 49)
Sponsors
- Representative Heath Sessions · Primary
Sponsorship breakdown
Export CSV (upgrade) →1 sponsors · 0 co-sponsors · 169 not signed on
Sponsors (1)
Co-sponsors (0)
None.
Not signed on (169)
169 members have not signed on to this bill.
Show all 169 →"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.
Subjects
Frequently asked questions
- What does H 4382 do?
- Nonprescription Ephedrine Products
- Who sponsors H 4382?
- H 4382 is sponsored by Representative Heath Sessions.
- What is the current status of H 4382?
- This bill has been enacted into law. Introduced April 23, 2025. Enacted.
- Where can I track H 4382?
- Track H 4382 free on One Click Politics — get push/email alerts when it moves.
Make your voice heard on H 4382
Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.
Stay ahead of H 4382
Last checked for changes 4 months ago · updated continuously
One Click Politics tracks every bill in Congress and all 50 states.
Track this bill →